Fetal Growth Restriction Clinical Trial
Official title:
A Randomized Air Filter Intervention Study of Air Pollution and Fetal Growth in a Highly Polluted Community
NCT number | NCT01741051 |
Other study ID # | 275997 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2014 |
Est. completion date | December 2019 |
Verified date | January 2020 |
Source | Simon Fraser University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to use an air filter intervention to evaluate the relationship
between particulate matter air pollution exposure during pregnancy and fetal growth. We
hypothesize that: 1) portable high efficiency air (HEPA) filters will produce major
reductions in home indoor concentrations of particulate matter and 2) pregnant women whose
exposures to particulate matter are reduced by this intervention will give birth to children
with greater mean body weight for gestational age.
In an extended follow-up of this cohort, we aim to evaluate the relationship between use of
portable air purifiers during pregnancy and the growth and development of children from birth
to age four years. In particular, the follow-up study will focus on children's physical
growth, respiratory symptoms, and behavioral, social and neurocognitive development.
Status | Completed |
Enrollment | 540 |
Est. completion date | December 2019 |
Est. primary completion date | December 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adult (>18 years) - Pregnant woman in first trimester (<14 weeks) - Single gestation pregnancy - Non-smoker Exclusion Criteria: - Multiple-gestation pregnancy - Current smoker - Currently operating an air filter in the home - Currently living in a ger (traditional Mongolian felt-lined yurt) - Plan to give birth outside of a hospital or clinic in Ulaanbaatar |
Country | Name | City | State |
---|---|---|---|
Mongolia | Mongolia National University of Medical Sciences | Ulaanbaatar |
Lead Sponsor | Collaborator |
---|---|
Simon Fraser University | Canadian Institutes of Health Research (CIHR) |
Mongolia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Gestational-age adjusted birthweight | At birth | ||
Primary | Birthweight | At birth | ||
Primary | Gestational age | At birth | ||
Primary | Head circumference | At birth | ||
Primary | Small for gestational age | <10%ile of birth weight for gestational age | At birth | |
Primary | Birth length | Birth length | At birth | |
Primary | Child body mass index | BMI = weight(kg)/height(m)^2 | Age 2 years | |
Primary | Child body mass index | BMI = weight(kg)/height(m)^2 | Age 4 years | |
Primary | Child wheeze | Parent-reported wheeze (ever/never and phenotypes) | Annually from birth to age 4 years | |
Primary | Child behavioural development | Sub-scales and composite scores from the Behavior Assessment System for Children, Third Edition (BASC-3) | Age 2 years | |
Primary | Child behavioural development | Sub-scales and composite scores from the Behavior Assessment System for Children, Third Edition (BASC-3) | Age 4 years | |
Primary | Child neurocognitive development | Sub-scales and index scores from the Wechsler Preschool and Primary Scale of Intelligence, Fourth Edition (WPPSI-IV) | Age 4 years | |
Primary | Child social development | Social Responsiveness Scale, Second Edition (SRS-2) scores | Age 4 years | |
Secondary | Blood pressure | At approximately 10, 11, 30 and 31 weeks gestation | ||
Secondary | C-reactive protein | At approximately 10 and 30 weeks gestation | ||
Secondary | Stratified Analyses | For all variables, we will explore effect modification by maternal exposure to environmental tobacco smoke, fraction of time spent at home, sex of the baby, season of birth, gestational age at birth, and the fraction of time that the HEPA filter(s) were used. | Various |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Recruiting |
NCT05601375 -
Speckle Tracking Echocardiography in Infants, Prenatally and Postnatally
|
||
Recruiting |
NCT03662178 -
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
|
||
Completed |
NCT05059093 -
Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
|
||
Completed |
NCT03067298 -
Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening
|
||
Recruiting |
NCT01981824 -
Prediction of Growth Restricted Fetuses Using Femur Length to Mid-thigh Circumference Ratio: A Case-control Study
|
N/A | |
Recruiting |
NCT04215107 -
Fetal Distribution of Feto-placental Blood Flow Related to Placental Nutrient Transport and Maternal Food Intake
|
N/A | |
Completed |
NCT02189148 -
First-trimester Prediction of Preeclampsia
|
||
Terminated |
NCT04084990 -
Sleep Apnea and Fetal Growth Restriction
|
Phase 3 | |
Recruiting |
NCT04051567 -
Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies
|
Phase 4 | |
Recruiting |
NCT04394611 -
Metals and in Fetal Growth Restriction
|
||
Completed |
NCT01369940 -
The NICHD Fetal Growth Study: Twin Gestations
|
N/A | |
Not yet recruiting |
NCT03121196 -
Social Deprivation and Pregnancy
|
N/A | |
Recruiting |
NCT03177824 -
Sildenafil Citrate for Treatment of Growth-restricted Fetuses
|
Phase 3 | |
Completed |
NCT02379832 -
Pre-Eclampsia And Growth Restriction: a Longitudinal Study
|
||
Completed |
NCT02379494 -
First Trimester Prediction of Preeclampsia and Fetal Growth Restriction
|
N/A | |
Completed |
NCT03046355 -
Timing of Delivery in Fetal Growth Restriction of Uncomplicated Women
|
N/A | |
Not yet recruiting |
NCT05848869 -
Prostaglandins Versus Trans-cervical Balloon for Induction of Labor in Fetal Growth Restriction
|
N/A | |
Recruiting |
NCT04438668 -
Evaluation of the Safety and Performance of Centaflow
|
N/A | |
Recruiting |
NCT05423665 -
Speckle Tracking Echocardiography as a Tool for Early Diagnosis of Impaired Fetal Growth Twin Pregnancies
|